Stockreport

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update [Yahoo! Finance]

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF Extensive preclinical data on SON-1210 published in Frontiers in Immunology Received approval and executed agreement to sell New Jersey state net operating losses (NO [Read more]